Skip to content

Individual Neurophysiological Sensory Profiles in People With and Without Neurodevelopmental Disorders

Individual Neurophysiological Sensory Profiles in People With and Without Neurodevelopmental Disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07542977
Acronym
SensAUry
Enrollment
200
Registered
2026-04-21
Start date
2026-05-07
Completion date
2028-06-15
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Keywords

Sensory, Neurophysiology, Profile

Brief summary

The goal of this observational study is to evaluate intra-individual neurophysiological variability in children and adults with and without NeuroDevelopmental Disorders (NDD), for several sensory modalities and types of stimulation. The main hypotheses are: * NDD participants and children exhibit higher intra-individual variability than other participants * intra-individual neurophysiological variability is correlated to behavioral, psychological and learning profiles Participants in this study will: * be recorded for EEG and other neurophysiological parameters while exposed to sensory stimulations, to quantify sensory neurophysiological variability * perform behavioral tests and fill out questionnaires, to establish the behavioral and psychological profile * train for perceptual learning, to measure learning abilities These evaluations will be split in 3 visits spread on a maximum of 3 months, and training for learning will be done at home in between 2 visits.

Interventions

None listed

Sponsors

University Hospital, Tours
Lead SponsorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Social security affiliation * Free and written informed consent from the participants (Neurotypical Adults, NDD Adults without judicial protective measures), or their tutor or legal representant(s) (other participants) * Age between 6 and 12 years included (Children) or between 18 and 45 years included (Adults) * For NDD participants: NDD diagnosis by a qualified medical professional, according to DSM-4, DSM-5, ICD-10 or ICD-11 criteria Non-inclusion Criteria: * Psychotropic medication perturbing EEG recording * Drugs pertubing peripheral neurophysiological measures * Non-corrected visual or auditory troubles * Known neurological or psychiatric conditions (at the exclusion of NDD for NDD participants) * Epilepsy * Inclusion in another ongoing medical protocol * For Neurotypical participants: NDD diagnosis * For NDD participants: anticipated psychological or physical risk at participating, at the investigator's discretion

Exclusion criteria

* Participants with no data to evaluate Outcome 1

Design outcomes

Primary

MeasureTime frameDescription
Amplitude of central neurophysiological responses to sensory stimulationsThrough study completion, an average of 2 months per participantAmplitude (in micro-volts) of event-related potentials
Latency of central neurophysiological responses to sensory stimulationsThrough study completion, an average of 2 months per participantLatency (in milli-seconds) of event-related potentials
Variability of central neurophysiological responses to sensory stimulationsThrough study completion, an average of 2 months per participantIntra-individual variability (in percentage) of event-related potentials

Secondary

MeasureTime frameDescription
Visual perceptual learning performanceThrough study completion, an average of 2 months per participantDiscrimination performance (in percentage) for visual delayed-matching to sample task
Auditory perceptual learning performanceThrough study completion, an average of 2 months per participantDiscrimination performance (in percentage) for auditory delayed-matching to sample task
Behavioral sensory profileThrough study completion, an average of 2 months per participantScore (in absolute score) for psychomotor evaluation (Échelle des Particularités Sensori-psychomotrices dans l'Autisme)
Sensory profile questionnaireThrough study completion, an average of 2 months per participantScore (in absolute score) for sensory questionnaire (Dunn Sensory Profile)
Cognitive psychological profileThrough study completion, an average of 2 months per participantScore (in absolute score) for cognitive test (Raven's Progressive Matrices)
Executive functions questionnaireThrough study completion, an average of 2 months per participantScore (in absolute score) for executive functions questionnaire (BRIEF or BRIEF-A depending on the group)
Attentional functions questionnaireThrough study completion, an average of 2 months per participantScore (in absolute score) for attentional functions questionnaire (SNAP-IV-26 or ASRS-V1.1 depending on the group)
Socio-emotional questionnaireThrough study completion, an average of 2 months per participantScore (in absolute score) for socio-emotional questionnaire (AQ)
Linguistic profileThrough study completion, an average of 2 months per participantScore (in absolute score) for non-words and sentences repetition (LITMUS)
Heart beat response to sensory stimulationsThrough study completion, an average of 2 months per participantHeart beat variation (in milliseconds) following sensory stimulation, recorded simultaneously with EEG
Electrodermal activity response to sensory stimulationsThrough study completion, an average of 2 months per participantElectrodermal activity variation (in microsiemens) following sensory stimulation, recorded simultaneously with EEG
Pupillary response to sensory stimulationsThrough study completion, an average of 2 months per participantPupillary diameter variation (in millimeter) following sensory stimulation,recorded simultaneously with EEG

Countries

France

Contacts

CONTACTClaire WARDAK, Dr
claire.wardak@univ-tours.fr02 47 47 97 47
CONTACTAdeline MOUSSET
a.fourmy@chu-tours.fr0218370645

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026